DE69608248D1 - Iontophoresevorrichtung zur transdermalen verabreichung von wirkstoffen vom typ anionische oligosaccaride - Google Patents

Iontophoresevorrichtung zur transdermalen verabreichung von wirkstoffen vom typ anionische oligosaccaride

Info

Publication number
DE69608248D1
DE69608248D1 DE69608248T DE69608248T DE69608248D1 DE 69608248 D1 DE69608248 D1 DE 69608248D1 DE 69608248 T DE69608248 T DE 69608248T DE 69608248 T DE69608248 T DE 69608248T DE 69608248 D1 DE69608248 D1 DE 69608248D1
Authority
DE
Germany
Prior art keywords
pct
electrodes
per
negative electrode
active principle
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69608248T
Other languages
English (en)
Other versions
DE69608248T2 (de
Inventor
Daniel Muller
Alain Barbier
Henry Saunal
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Societe National Elf Aquitaine
Sanofi Aventis France
Original Assignee
Societe National Elf Aquitaine
Sanofi SA
Akzo Nobel NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Societe National Elf Aquitaine, Sanofi SA, Akzo Nobel NV filed Critical Societe National Elf Aquitaine
Publication of DE69608248D1 publication Critical patent/DE69608248D1/de
Application granted granted Critical
Publication of DE69608248T2 publication Critical patent/DE69608248T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00Electrotherapy; Circuits therefor
    • A61N1/02Details
    • A61N1/04Electrodes
    • A61N1/0404Electrodes for external use
    • A61N1/0408Use-related aspects
    • A61N1/0428Specially adapted for iontophoresis, e.g. AC, DC or including drug reservoirs
    • A61N1/0432Anode and cathode
    • A61N1/0436Material of the electrode
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00Electrotherapy; Circuits therefor
    • A61N1/02Details
    • A61N1/04Electrodes
    • A61N1/0404Electrodes for external use
    • A61N1/0408Use-related aspects
    • A61N1/0428Specially adapted for iontophoresis, e.g. AC, DC or including drug reservoirs
    • A61N1/0432Anode and cathode
    • A61N1/044Shape of the electrode
DE69608248T 1995-01-24 1996-01-24 Iontophoresevorrichtung zur transdermalen verabreichung von wirkstoffen vom typ anionische oligosaccaride Expired - Lifetime DE69608248T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9500757A FR2729574B1 (fr) 1995-01-24 1995-01-24 Dispositif d'ionophorese pour l'administration transcutanee d'un principe actif de type oligosaccharide anionique
PCT/FR1996/000114 WO1996022808A1 (fr) 1995-01-24 1996-01-24 Dispositif d'ionophorese pour l'administration transcutanee d'un principe actif de type oligosaccharide anionique

Publications (2)

Publication Number Publication Date
DE69608248D1 true DE69608248D1 (de) 2000-06-15
DE69608248T2 DE69608248T2 (de) 2001-01-04

Family

ID=9475415

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69608248T Expired - Lifetime DE69608248T2 (de) 1995-01-24 1996-01-24 Iontophoresevorrichtung zur transdermalen verabreichung von wirkstoffen vom typ anionische oligosaccaride

Country Status (12)

Country Link
US (1) US5928185A (de)
EP (1) EP0805706B1 (de)
JP (2) JP3856240B2 (de)
AT (1) ATE192664T1 (de)
AU (1) AU4626196A (de)
DE (1) DE69608248T2 (de)
DK (1) DK0805706T3 (de)
ES (1) ES2154397T3 (de)
FR (1) FR2729574B1 (de)
GR (1) GR3034097T3 (de)
PT (1) PT805706E (de)
WO (1) WO1996022808A1 (de)

Families Citing this family (53)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5797867A (en) * 1996-09-27 1998-08-25 Becton Dickinson And Company Iontophoretic drug delivery system, including method for activating same for attachment to patient
CA2382599C (en) * 1999-08-30 2005-11-08 Tepha, Inc. Flushable disposable polymeric products
AU2003226605A1 (en) 2002-04-19 2003-11-03 Transpharma Medical Ltd. Handheld transdermal drug delivery and analyte extraction
US7031769B2 (en) * 2003-02-21 2006-04-18 Birch Point Medical, Inc. Dosage control electrode for iontophoresis device
US7507228B2 (en) * 2003-06-30 2009-03-24 Johnson & Johnson Consumer Companies, Inc. Device containing a light emitting diode for treatment of barrier membranes
US7479133B2 (en) * 2003-06-30 2009-01-20 Johnson & Johnson Consumer Companies, Inc. Methods of treating acne and rosacea with galvanic generated electricity
US7480530B2 (en) * 2003-06-30 2009-01-20 Johnson & Johnson Consumer Companies, Inc. Device for treatment of barrier membranes
US7486989B2 (en) * 2003-06-30 2009-02-03 Johnson & Johnson Consumer Companies, Inc. Device for delivery of oxidizing agents to barrier membranes
US7477941B2 (en) * 2003-06-30 2009-01-13 Johnson & Johnson Consumer Companies, Inc. Methods of exfoliating the skin with electricity
US7477940B2 (en) * 2003-06-30 2009-01-13 J&J Consumer Companies, Inc. Methods of administering an active agent to a human barrier membrane with galvanic generated electricity
US8734421B2 (en) * 2003-06-30 2014-05-27 Johnson & Johnson Consumer Companies, Inc. Methods of treating pores on the skin with electricity
US7477938B2 (en) * 2003-06-30 2009-01-13 Johnson & Johnson Cosumer Companies, Inc. Device for delivery of active agents to barrier membranes
US7476222B2 (en) * 2003-06-30 2009-01-13 Johnson & Johnson Consumer Companies, Inc. Methods of reducing the appearance of pigmentation with galvanic generated electricity
US20040265395A1 (en) * 2003-06-30 2004-12-30 Ying Sun Device for delivery of reducing agents to barrier membranes
JP2007037868A (ja) * 2005-08-05 2007-02-15 Transcutaneous Technologies Inc 経皮投与装置及びその制御方法
US8386030B2 (en) * 2005-08-08 2013-02-26 Tti Ellebeau, Inc. Iontophoresis device
US8295922B2 (en) * 2005-08-08 2012-10-23 Tti Ellebeau, Inc. Iontophoresis device
US20070060860A1 (en) * 2005-08-18 2007-03-15 Transcutaneous Technologies Inc. Iontophoresis device
WO2007026672A1 (ja) * 2005-08-29 2007-03-08 Transcu Ltd. イオントフォレーシス用汎用性電解液組成物
JPWO2007032446A1 (ja) 2005-09-15 2009-03-19 Tti・エルビュー株式会社 ロッド型イオントフォレーシス装置
WO2007037324A1 (ja) * 2005-09-28 2007-04-05 Transcu Ltd. 乾燥型イオントフォレーシス用電極構造体
JP2009509659A (ja) * 2005-09-30 2009-03-12 Tti・エルビュー株式会社 生体界面への活性物質の送達のイオントフォレーシス装置及び方法
WO2007041322A2 (en) * 2005-09-30 2007-04-12 Tti Ellebeau, Inc. Iontophoretic delivery of active agents conjugated to nanoparticles
US20070232983A1 (en) * 2005-09-30 2007-10-04 Smith Gregory A Handheld apparatus to deliver active agents to biological interfaces
US7574256B2 (en) * 2005-09-30 2009-08-11 Tti Ellebeau, Inc. Iontophoretic device and method of delivery of active agents to biological interface
US20070074590A1 (en) * 2005-09-30 2007-04-05 Transcutaneous Technologies Inc. Method and system to detect malfunctions in an iontophoresis device that delivers active agents to biological interfaces
JP2009522011A (ja) 2005-12-30 2009-06-11 Tti・エルビュー株式会社 活性物質を生体界面に送達するイオントフォレーシスシステム、装置及び方法
KR20090027755A (ko) * 2006-07-05 2009-03-17 티티아이 엘뷰 가부시키가이샤 자기-조립형 수지상 중합체를 함유하는 전달 장치 및 이의 사용 방법
US8062783B2 (en) * 2006-12-01 2011-11-22 Tti Ellebeau, Inc. Systems, devices, and methods for powering and/or controlling devices, for instance transdermal delivery devices
US8197844B2 (en) 2007-06-08 2012-06-12 Activatek, Inc. Active electrode for transdermal medicament administration
US20100036269A1 (en) * 2008-08-07 2010-02-11 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Circulatory monitoring systems and methods
US9672471B2 (en) 2007-12-18 2017-06-06 Gearbox Llc Systems, devices, and methods for detecting occlusions in a biological subject including spectral learning
US9717896B2 (en) 2007-12-18 2017-08-01 Gearbox, Llc Treatment indications informed by a priori implant information
US8862223B2 (en) 2008-01-18 2014-10-14 Activatek, Inc. Active transdermal medicament patch and circuit board for same
US8996104B2 (en) * 2008-06-25 2015-03-31 Fe3 Medical, Inc. Patches and method for the transdermal delivery of a therapeutically effective amount of iron
US8150525B2 (en) * 2008-08-27 2012-04-03 Johnson & Johnson Consumer Companies, Inc. Treatment of hyperhydrosis
US9008765B2 (en) 2009-02-12 2015-04-14 Incube Labs, Llc System and method for biphasic transdermal iontophoretic delivery of therapeutic agents for the control of addictive cravings
US8190252B2 (en) * 2009-02-12 2012-05-29 Incube Labs, Llc Iontophoretic system for transdermal delivery of active agents for therapeutic and medicinal purposes
US8961492B2 (en) 2009-02-12 2015-02-24 Incube Labs, Llc System and method for controlling the iontophoretic delivery of therapeutic agents based on user inhalation
US9095503B2 (en) 2009-02-12 2015-08-04 Incube Labs, Llc System and method for biphasic transdermal iontophreotic delivery of therapeutic agents
WO2010093472A2 (en) * 2009-02-12 2010-08-19 Incube Labs, Llc Method and apparatus for oscillatory iontophoretic transdermal delivery of a therapeutic agent
US8606366B2 (en) 2009-02-18 2013-12-10 Syneron Medical Ltd. Skin treatment apparatus for personal use and method for using same
US20120089232A1 (en) 2009-03-27 2012-04-12 Jennifer Hagyoung Kang Choi Medical devices with galvanic particulates
US8821945B2 (en) * 2009-04-25 2014-09-02 Fe3 Medical, Inc. Method for transdermal iontophoretic delivery of chelated agents
WO2010151845A2 (en) * 2009-06-26 2010-12-29 Incube Labs, Llc Corrosion resistant electrodes for iontophoretic transdermal delivery devices and methods of use
US8903485B2 (en) * 2009-08-06 2014-12-02 Incube Labs, Llc Patch and patch assembly for iontophoretic transdermal delivery of active agents for therapeutic and medicinal purposes
US8744567B2 (en) * 2009-11-13 2014-06-03 Johnson & Johnson Consumer Companies, Inc. Galvanic skin treatment device
US8685038B2 (en) 2009-12-07 2014-04-01 Incube Labs, Llc Iontophoretic apparatus and method for marking of the skin
WO2011100376A2 (en) 2010-02-10 2011-08-18 Incube Labs, Llc Methods and architecture for power optimization of iontophoretic transdermal drug delivery
US10342968B2 (en) * 2010-12-22 2019-07-09 Teikoku Seiyaku Co., Ltd. Electrode pad used for iontophoresis treatment
WO2014207750A1 (en) * 2013-06-28 2014-12-31 Yosef Gross International Technologies Ltd. Skin-care system
CA3074777A1 (en) * 2017-09-12 2019-03-21 Lts Lohmann Therapie-Systeme Ag Iontophoretic microneedle device
WO2023234145A1 (ja) * 2022-05-30 2023-12-07 キッコーマン株式会社 経皮通電パッチ

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0300099A1 (de) * 1987-07-20 1989-01-25 Akzo N.V. Pentasaccharide
US5068226A (en) * 1987-12-07 1991-11-26 Cyclex, Inc. Pharmaceutical preparations containing cyclodextrins and their use in iontophoretic therapies
US5320597A (en) * 1991-02-08 1994-06-14 Becton, Dickinson And Company Device and method for renewing electrodes during iontophoresis
FR2687321B1 (fr) * 1992-02-14 1999-04-16 Elf Aquitaine Dispositif d'ionophorese pour l'administration transcutanee d'une quantite totale donnee d'un principe actif a un sujet.

Also Published As

Publication number Publication date
US5928185A (en) 1999-07-27
ES2154397T3 (es) 2001-04-01
DE69608248T2 (de) 2001-01-04
EP0805706A1 (de) 1997-11-12
ATE192664T1 (de) 2000-05-15
FR2729574A1 (fr) 1996-07-26
WO1996022808A1 (fr) 1996-08-01
JPH10512776A (ja) 1998-12-08
FR2729574B1 (fr) 1997-07-04
EP0805706B1 (de) 2000-05-10
DK0805706T3 (da) 2000-10-02
JP2006341107A (ja) 2006-12-21
GR3034097T3 (en) 2000-11-30
AU4626196A (en) 1996-08-14
PT805706E (pt) 2000-10-31
JP3856240B2 (ja) 2006-12-13

Similar Documents

Publication Publication Date Title
DE69608248D1 (de) Iontophoresevorrichtung zur transdermalen verabreichung von wirkstoffen vom typ anionische oligosaccaride
CA2002849C (en) Method and apparatus for iontophoretic drug delivery
MXPA02011842A (es) Dispositivo de suministro electrocinetico.
ATE358510T1 (de) Vorrichtung zur iontophoretischen verabreichung von medikamenten durch das augenlid
MX174131B (es) Electrodo de iontoforesis
EP0904801A3 (de) Verfahren zum Feststellen von Ereignissen und Zuständen in einer iontophoretischen Verabreichungs-Vorrichtung
DE69427526T2 (de) Applikator zur transkutanen verabreichung eines medikaments
DE69133328D1 (de) Vorrichtung zur iontophoretischen verabreichung
EP1195175A3 (de) Vorrichtung zur Verabreichung von Medikamenten durch Iontophorese
FR2506165A1 (fr) Dispositif pour un traitement d'ionophorese
ATE310459T1 (de) Gerät zur denervierung des intraossalnervs
ATE184206T1 (de) Vorrichtung zur erhöhung der wirkstoffsverabreichung durch elektrotransport
DE69712316D1 (en) Modulation der th1/th2 cytokinexpression durch ribavirin in aktivierten t-lymphozyten
DK256390A (da) Elektrisk apparat omfattende en elektrode til kontakt med en elektrolyt
WO2001079706A3 (en) Electrolytic cell
CA2132348A1 (en) User Activated Iontophoretic Device and Method for Using Same
MX170809B (es) Electrodo de iontoforesis
CA2211794A1 (fr) Dispositif d'ionophorese pour l'administration transcutanee d'un principe actif de type oligosaccharide anionique
WO2000054834A1 (en) Sweat control system
JP2821267B2 (ja) イオン導入法によって薬剤を供給する装置および方法
CN110496306A (zh) 密合式电离牙齿美白仪
JP2004236722A (ja) 美顔器の使用方法及び美顔器
JPH10314316A (ja) 磁気イオンブラシ
JPS602207A (ja) エレキ歯ブラシ
SE9700537L (sv) Strömbegränsare

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: AKZO NOBEL N.V., ARNHEIM/ARNHEM, NL SANOFI-SYNTHEL

8327 Change in the person/name/address of the patent owner

Owner name: AKZO NOBEL N.V., ARNHEIM/ARNHEM, NL ELF AQUITAINE,

8327 Change in the person/name/address of the patent owner

Owner name: SANOFI-SYNTHELABO, PARIS, FR

Owner name: ELF AQUITAINE, COURBEVOIE, FR

8327 Change in the person/name/address of the patent owner

Owner name: SANOFI-AVENTIS, PARIS, FR

Owner name: ELF AQUITAINE, COURBEVOIE, FR

R082 Change of representative

Ref document number: 805706

Country of ref document: EP

Representative=s name: V. FUENER EBBINGHAUS FINCK HANO, DE